Effect of Combined Proteinuria and Increased Renal Resistive Index on Chronic Kidney Disease Progression: A Retrospective Longitudinal Study.

IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Giulio Romano, Nicholas Fiorini, Martina Bertoni, Stefania Rondinella, Laura Di Pietra, Marco F Cola, Paolo De Martin, Maurizio Tonizzo, Lorenzo Desinan, Benedetta Boari, Roberto Manfredini, GianLuca Colussi
{"title":"Effect of Combined Proteinuria and Increased Renal Resistive Index on Chronic Kidney Disease Progression: A Retrospective Longitudinal Study.","authors":"Giulio Romano, Nicholas Fiorini, Martina Bertoni, Stefania Rondinella, Laura Di Pietra, Marco F Cola, Paolo De Martin, Maurizio Tonizzo, Lorenzo Desinan, Benedetta Boari, Roberto Manfredini, GianLuca Colussi","doi":"10.3390/jcm14010228","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> An increased renal resistive index (RRI) and proteinuria can predict an estimated glomerular filtration rate (eGFR) decline in patients with chronic kidney disease (CKD) of various causes. This study hypothesized that the RRI and proteinuria interact to determine disease progression in patients with CKDs of unknown origin. <b>Patients and Methods</b>: One hundred and fifty six patients (age 76.0 ± 8.1 years, 63.5% males) were analyzed for anthropometric, kidney morphology, blood pressure, 24 h urinary protein excretion, and RRI. The CKD-EPI equation was used to calculate the eGFR at baseline and after a two-year follow-up. Patients with an elevated (≥0.80) or normal (<0.80) RRI and significant (≥150 mg/day) or physiological (<150 mg/day) proteinuria were evaluated for the likelihood of at least a 30% drop in the eGFR or the onset of end-stage kidney disease (endpoint). <b>Results</b>: Hypertension and diabetes were the predominant cardiovascular risk factors (90.4%). Fifty patients (32%) met the endpoint. Elevated RRIs (odds ratio, OR, 4.28; 95% confidence interval, CI, 1.82-10.6; <i>p</i> = 0.001) and significant proteinuria (OR 3.59, 95% CI 1.59-8.48, <i>p</i> = 0.003) were independent predictors of the endpoint in a multivariate logistic model. Patients with an elevated RRI and significant proteinuria were more likely to meet the endpoint (R1P1: 65.2%) compared to those with only proteinuria (R0P1: 39.5%, <i>p</i> = 0.043) or both normal factors (R0P0: 10.9%, <i>p</i> < 0.001) but not to those with only an elevated RRI (R1P0: 42.3%, <i>p</i> = 0.094). Continuous RRIs (partial correlation r = -0.245, <i>p</i> < 0.001) and 24 h urinary protein excretion (partial r = -0.226, <i>p</i> = 0.003) were inversely and independently correlated with eGFR% change. R1P1 showed a higher eGFR% reduction (-38.0% ± 20.4%) compared to R0P1 (-25.3% ± 19.0%, <i>p</i> = 0.043) and R0P0 (-8.8% ± 25.1%, <i>p</i> < 0.001) but not to R1P0 (-29.6% ± 21.0%, <i>p</i> = 0.192). <b>Conclusions</b>: An increased RRI and proteinuria were independent predictors of disease progression. When interaction was considered, the negative effect of an elevated RRI on CKD progression was evident in both proteinuric and non-proteinuric patients, whereas the negative effect of proteinuria on disease progression was only significant in patients with no elevated RRIs.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 1","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11721810/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jcm14010228","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: An increased renal resistive index (RRI) and proteinuria can predict an estimated glomerular filtration rate (eGFR) decline in patients with chronic kidney disease (CKD) of various causes. This study hypothesized that the RRI and proteinuria interact to determine disease progression in patients with CKDs of unknown origin. Patients and Methods: One hundred and fifty six patients (age 76.0 ± 8.1 years, 63.5% males) were analyzed for anthropometric, kidney morphology, blood pressure, 24 h urinary protein excretion, and RRI. The CKD-EPI equation was used to calculate the eGFR at baseline and after a two-year follow-up. Patients with an elevated (≥0.80) or normal (<0.80) RRI and significant (≥150 mg/day) or physiological (<150 mg/day) proteinuria were evaluated for the likelihood of at least a 30% drop in the eGFR or the onset of end-stage kidney disease (endpoint). Results: Hypertension and diabetes were the predominant cardiovascular risk factors (90.4%). Fifty patients (32%) met the endpoint. Elevated RRIs (odds ratio, OR, 4.28; 95% confidence interval, CI, 1.82-10.6; p = 0.001) and significant proteinuria (OR 3.59, 95% CI 1.59-8.48, p = 0.003) were independent predictors of the endpoint in a multivariate logistic model. Patients with an elevated RRI and significant proteinuria were more likely to meet the endpoint (R1P1: 65.2%) compared to those with only proteinuria (R0P1: 39.5%, p = 0.043) or both normal factors (R0P0: 10.9%, p < 0.001) but not to those with only an elevated RRI (R1P0: 42.3%, p = 0.094). Continuous RRIs (partial correlation r = -0.245, p < 0.001) and 24 h urinary protein excretion (partial r = -0.226, p = 0.003) were inversely and independently correlated with eGFR% change. R1P1 showed a higher eGFR% reduction (-38.0% ± 20.4%) compared to R0P1 (-25.3% ± 19.0%, p = 0.043) and R0P0 (-8.8% ± 25.1%, p < 0.001) but not to R1P0 (-29.6% ± 21.0%, p = 0.192). Conclusions: An increased RRI and proteinuria were independent predictors of disease progression. When interaction was considered, the negative effect of an elevated RRI on CKD progression was evident in both proteinuric and non-proteinuric patients, whereas the negative effect of proteinuria on disease progression was only significant in patients with no elevated RRIs.

蛋白尿和肾抵抗指数升高对慢性肾病进展的影响:一项回顾性纵向研究。
导读:肾抵抗指数(RRI)和蛋白尿的增加可以预测各种原因的慢性肾脏疾病(CKD)患者肾小球滤过率(eGFR)的下降。本研究假设RRI和蛋白尿相互作用决定病因不明的ckd患者的疾病进展。患者和方法:对156例患者(年龄76.0±8.1岁,男性63.5%)进行人体测量、肾脏形态、血压、24 h尿蛋白排泄和RRI分析。使用CKD-EPI方程计算基线时和两年随访后的eGFR。结果:高血压和糖尿病是主要的心血管危险因素(90.4%)。50名患者(32%)达到了终点。风险风险比升高(优势比OR, 4.28;95%置信区间,CI, 1.82-10.6;p = 0.001)和显著蛋白尿(OR 3.59, 95% CI 1.59-8.48, p = 0.003)是多变量logistic模型中终点的独立预测因子。与仅存在蛋白尿的患者(R0P1: 39.5%, p = 0.043)或两种正常因素的患者(R0P0: 10.9%, p < 0.001)相比,RRI升高和明显蛋白尿的患者更有可能达到终点(R1P1: 65.2%),但与仅存在RRI升高的患者(R1P0: 42.3%, p = 0.094)相比,R1P1: 65.2%更容易达到终点。连续RRIs(偏相关r = -0.245, p < 0.001)和24 h尿蛋白排泄量(偏相关r = -0.226, p = 0.003)与eGFR%变化呈独立负相关。R1P1的eGFR%降低率(-38.0%±20.4%)高于R0P1(-25.3%±19.0%,p = 0.043)和R0P0(-8.8%±25.1%,p < 0.001),但低于R1P0(-29.6%±21.0%,p = 0.192)。结论:RRI升高和蛋白尿是疾病进展的独立预测因子。当考虑到相互作用时,在蛋白尿和非蛋白尿患者中,RRI升高对CKD进展的负面影响都很明显,而蛋白尿对疾病进展的负面影响仅在没有RRIs升高的患者中才显著。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Medicine
Journal of Clinical Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
5.70
自引率
7.70%
发文量
6468
审稿时长
16.32 days
期刊介绍: Journal of Clinical Medicine (ISSN 2077-0383), is an international scientific open access journal, providing a platform for advances in health care/clinical practices, the study of direct observation of patients and general medical research. This multi-disciplinary journal is aimed at a wide audience of medical researchers and healthcare professionals. Unique features of this journal: manuscripts regarding original research and ideas will be particularly welcomed.JCM also accepts reviews, communications, and short notes. There is no limit to publication length: our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信